Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence

Front Immunol. 2024 Feb 21:15:1377041. doi: 10.3389/fimmu.2024.1377041. eCollection 2024.

Authors

Lorenzo Federico^{1

2}, Brandon Malone³, Simen Tennøe³, Viktoriia Chaban^{1

2}, Julie Røkke Osen^{1

2}, Murat Gainullin^{1

2}, Eva Smorodina^{1

4}, Hassen Kared^{1

2}, Rahmad Akbar^{1

4}, Victor Greiff^{1

4}, Richard Stratford³, Trevor Clancy³, Ludvig Andre Munthe^{1

2}

Affiliations

¹ Department of Immunology, Oslo University Hospital, Oslo, Norway.
² KG Jebsen Centre for B cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
³ NEC OncoImmunity AS, Oslo, Norway.
⁴ Institute of Clinical Medicine, Oslo University Hospital, Oslo, Norway.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1265044.].

Keywords: CD4+ lymphocytes; CD8+ lymphocytes; COVID-19; SARS-CoV-2; T cell; antigen (Ag); artificial intelligence; vaccine.

Copyright © 2024 Federico, Malone, Tennøe, Chaban, Osen, Gainullin, Smorodina, Kared, Akbar, Greiff, Stratford, Clancy and Munthe.

Publication types

Published Erratum